These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 22831901)

  • 1. Menstrual suppression with the levonorgestrel intrauterine system in girls with developmental delay.
    Hillard PJ
    J Pediatr Adolesc Gynecol; 2012 Oct; 25(5):308-13. PubMed ID: 22831901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of the levonorgestrel intrauterine system in adolescents with endometriosis.
    Yoost J; LaJoie AS; Hertweck P; Loveless M
    J Pediatr Adolesc Gynecol; 2013 Apr; 26(2):120-4. PubMed ID: 23518190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resources and procedures in the treatment of heavy menstrual bleeding with the levonorgestrel-releasing intrauterine system (LNG-IUS) or hysterectomy in Brazil.
    Bahamondes MV; de Lima Y; Teich V; Bahamondes L; Monteiro I
    Contraception; 2012 Sep; 86(3):244-50. PubMed ID: 22459236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomised trial comparing the levonorgestrel intrauterine system and thermal balloon ablation for heavy menstrual bleeding.
    Busfield RA; Farquhar CM; Sowter MC; Lethaby A; Sprecher M; Yu Y; Sadler LC; Brown P; Johnson N
    BJOG; 2006 Mar; 113(3):257-63. PubMed ID: 16487195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levonorgestrel-releasing intrauterine system for menstrual dysfunction: patient satisfaction in the district general hospital setting.
    Macnab JL; Lowles IE
    J Obstet Gynaecol; 2002 Jul; 22(4):402-5. PubMed ID: 12521465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomised comparative trial of the levonorgestrel intrauterine system and mefenamic acid for the treatment of idiopathic menorrhagia: a multiple analysis using total menstrual fluid loss, menstrual blood loss and pictorial blood loss assessment charts.
    Reid PC; Virtanen-Kari S
    BJOG; 2005 Aug; 112(8):1121-5. PubMed ID: 16045528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of menorrhagia with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study.
    Wildemeersch D; Schacht E
    Eur J Contracept Reprod Health Care; 2001 Jun; 6(2):93-101. PubMed ID: 11518454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complication rates associated with levonorgestrel intrauterine system use in adolescents with developmental disabilities.
    Savasi I; Jayasinghe K; Moore P; Jayasinghe Y; Grover SR
    J Pediatr Adolesc Gynecol; 2014 Feb; 27(1):25-8. PubMed ID: 24315712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of oligoamenorrhea at 1-year follow-up in premenopausal women using a levonorgestrel-releasing intrauterine system.
    de Jonge ET; Yigit R; Molenberghs G; Straetmans D; Ombelet W
    Contraception; 2007 Aug; 76(2):91-5. PubMed ID: 17656176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in menstrual concerns and suppression in adolescents with developmental disabilities.
    Kirkham YA; Allen L; Kives S; Caccia N; Spitzer RF; Ornstein MP
    J Adolesc Health; 2013 Sep; 53(3):407-12. PubMed ID: 23763962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Femilis LNG-IUS: contraceptive performance-an interim analysis.
    Wildemeersch D; Janssens D; Andrade A
    Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):103-10. PubMed ID: 19340705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experiences of Gender Minority Youth With the Intrauterine System.
    Akgul S; Bonny AE; Ford N; Holland-Hall C; Chelvakumar G
    J Adolesc Health; 2019 Jul; 65(1):32-38. PubMed ID: 30691940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Menstrual blood loss in women using the frameless FibroPlant LNG-IUS.
    Andrade A; Wildemeersch D
    Contraception; 2009 Feb; 79(2):134-8. PubMed ID: 19135571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health effects of long-term use of the intrauterine levonorgestrel-releasing system. A follow-up study over 12 years of continuous use.
    Rönnerdag M; Odlind V
    Acta Obstet Gynecol Scand; 1999 Sep; 78(8):716-21. PubMed ID: 10468065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of levonorgestrel intrauterine system for medical indications in adolescents.
    Bayer LL; Hillard PJ
    J Adolesc Health; 2013 Apr; 52(4 Suppl):S54-8. PubMed ID: 23535058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of the levonorgestrel-releasing intrauterine system in women with hemostatic disorders.
    Lukes AS; Reardon B; Arepally G
    Fertil Steril; 2008 Sep; 90(3):673-7. PubMed ID: 18001734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Menstrual management in developmentally delayed adolescent females.
    Chuah I; McRae A; Matthews K; Maguire AM; Steinbeck K
    Aust N Z J Obstet Gynaecol; 2017 Jun; 57(3):346-350. PubMed ID: 28299789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uterine Length in Adolescents with Developmental Disability: Are Ultrasound Examinations Necessary before Insertion of the Levonorgestrel Intrauterine System?
    Whyte H; Pecchioli Y; Oyewumi L; Kives S; Allen LM; Kirkham YA
    J Pediatr Adolesc Gynecol; 2016 Dec; 29(6):648-652. PubMed ID: 27321898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subject and clinician experience with the levonorgestrel-releasing intrauterine system.
    Jensen JT; Nelson AL; Costales AC
    Contraception; 2008 Jan; 77(1):22-9. PubMed ID: 18082662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of menstrual blood loss in Belgian users of a new T-shaped levonorgestrel-releasing intrauterine system.
    Wildemeersch D; Rowe PJ
    Contraception; 2005 Jun; 71(6):470-3. PubMed ID: 15914139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.